Jones Criteria (Acute Rheumatic Fever)
Use this checklist for initial ARF assessment. Interpretation requires preceding GAS evidence and risk-adjusted major/minor thresholds.
Clinical disclaimer
Positive RADT/culture, elevated ASO or anti-DNase B
How to apply the criteria
Initial episode rule: evidence of preceding group A Streptococcus (GAS) infection and either (1) two or more major criteria or (2) one major plus two or more minor criteria, interpreted in the context of population risk. The calculator tallies major/minor features and displays combinations; you remain responsible for verifying GAS evidence and risk classification.
Acute phase findings can evolve—document serial exams. Carditis may be subclinical (echo-only). Polyarthritis often migratory involving large joints. Erythema marginatum and subcutaneous nodules are uncommon but specific. Chorea can present weeks to months later and may appear isolated.
Bedside workflow for suspected ARF
- Confirm fever timeline and document all principal features with day-by-day evolution.
- Obtain evidence of preceding GAS infection (culture/RADT or streptococcal antibody trend).
- Classify population risk setting (low vs moderate/high) before counting major/minor criteria.
- Use echocardiography early for suspected carditis, including subclinical presentations.
- Plan treatment and secondary prophylaxis follow-up with cardiology/infectious disease alignment.
Evidence of preceding streptococcal infection
- Positive throat culture or RADT for GAS.
- Elevated or rising streptococcal antibody titers (e.g., ASO, anti-DNase B); repeat in 1–2 weeks if initial titers are equivocal.
- Recent scarlet fever can serve as evidence when documented.
If no GAS evidence is present, reconsider the diagnosis and differentials. For isolated chorea, GAS evidence may be absent; clinical judgment and neurology/rheumatology input are key.
Major and minor criteria (risk-adjusted)
Major (both risk groups): carditis (clinical or subclinical), polyarthritis, chorea, erythema marginatum, subcutaneous nodules.
Minor (both risk groups): fever, arthralgia, elevated ESR/CRP, prolonged PR interval (age-adjusted), plus other acute-phase reactants per local policy.
- In moderate/high-risk settings, monoarthritis can qualify as a major criterion if no better explanation and inflammatory markers support ARF.
- Polyarthralgia may count as a major criterion in high-risk settings; arthralgia alone is minor in low-risk settings.
- Fever and ESR/CRP cutoffs may be slightly lower in high-risk populations—follow institutional thresholds.
Tailor interpretation to age and epidemiology. Low-risk regions generally require classic polyarthritis as a major criterion; high-risk regions allow mono/polyarthralgia to weigh more heavily.
Common pitfalls that delay diagnosis
- Counting criteria before confirming low-risk versus moderate/high-risk population context.
- Assuming normal initial echocardiogram excludes evolving carditis without planned follow-up.
- Dismissing isolated chorea or indolent carditis because systemic findings are incomplete.
- Failing to document secondary prophylaxis adherence history when recurrence is possible.
Immediate escalation triggers
- Signs of carditis or heart failure regardless of incomplete criteria tally.
- Neurologic concern for chorea with diagnostic uncertainty or progression.
- Persistent inflammatory syndrome with evolving features despite initial low confidence.
- Possible recurrence with prophylaxis gaps or prior rheumatic heart disease history.
Risk-pattern reassessment cadence
- Initial low-confidence case: re-evaluate within 24-48 hours if inflammatory trajectory is evolving.
- Suspected carditis/chorea or abnormal ECG/echo: same-shift specialist alignment and closer reassessment cadence.
- Recurrent-risk profile (prior ARF/RHD or prophylaxis gaps): shorten follow-up interval and confirm prophylaxis plan before discharge.
Recurrent ARF
Recurrent episodes have modified requirements: combinations of major/minor differ when there is prior ARF or established rheumatic heart disease. If recurrence is suspected, involve cardiology/rheumatology early and treat promptly—do not wait for all elements to declare. Secondary prophylaxis lapses (missed penicillin) raise suspicion.
- Common approach (AHA 2015): evidence of GAS plus either 2 major, or 1 major + 2 minor, or 3 minor if there is established rheumatic heart disease.
- Chorea alone or indolent carditis may represent recurrence even without full systemic findings.
Echocardiography, ECG, and monitoring
- Echo is recommended for all suspected ARF to detect subclinical carditis. Repeat if initial is indeterminate or if symptoms evolve.
- Obtain ECG (PR interval) and consider telemetry if conduction disease or heart failure symptoms.
- Baseline labs: ESR/CRP, CBC with platelets, CMP; repeat to track inflammatory trends and to support recurrent/incomplete presentations.
- Document murmurs carefully; regurgitant lesions (MR/AR) are common in rheumatic carditis.
Treatment and prophylaxis highlights
- Eradicate GAS: penicillin (IM benzathine or appropriate oral course) or macrolide if true anaphylactic allergy.
- Anti-inflammatory therapy: aspirin or naproxen for arthritis; corticosteroids may be used for severe carditis per cardiology/rheum.
- Heart failure management as indicated (diuretics/afterload reduction) with cardiology guidance.
- Secondary prophylaxis: long-term benzathine penicillin G (every 3–4 weeks) or oral alternatives; duration depends on presence/severity of carditis and valve disease (often years to lifelong for severe RHD).
Coordinate with cardiology and infectious diseases for regimen, duration, and patient/caregiver education. Adherence to prophylaxis is critical to prevent recurrence.
Differentials and when to escalate
- Post-streptococcal reactive arthritis (PSRA), JIA, lupus, Lyme, serum sickness–like reactions, viral myocarditis/pericarditis, MIS-C.
- Red flags for alternate diagnoses: septic arthritis pattern, purpuric rash, cytopenias, markedly elevated ferritin, or pericardial tamponade physiology.
- Escalate to ID/rheum/cardiology for diagnostic uncertainty, significant carditis, or if monoarthritis is present without clear ARF features.
Caregiver communication and follow-up
- Explain the need for GAS eradication and long-term prophylaxis to prevent recurrence and valve damage.
- Review return precautions: worsening dyspnea, edema, syncope, chest pain, or neurologic changes.
- Set expectations for follow-up: cardiology visits, repeat echo schedule, and adherence to prophylaxis injections or pills.
- Provide written plans and coordinate school/daycare notes for medication schedules and activity guidance if carditis is present.
Handoff template
- Population-risk classification and episode type (initial vs recurrent).
- Documented major/minor criteria with timing and evolution.
- GAS evidence status (RADT/culture/antibody trend) and pending labs.
- Echo/ECG findings and specialist consult status.
- Treatment/prophylaxis plan with follow-up interval and escalation trigger.
Escalation packet for specialist review
- Risk-group classification and episode type with rationale.
- Major/minor criteria mapped to timeline and exam findings.
- GAS evidence completed vs pending (culture/RADT/ASO/anti-DNase B).
- Cardiac data summary (murmur, ECG, echo findings, heart-failure signs).
- Immediate decision needed from cardiology/ID/rheumatology team.
Related tools
References
FAQs
You need evidence of preceding GAS infection plus either (1) two or more major criteria or (2) one major and at least two minor criteria, interpreted in the context of population risk (low vs moderate/high).
Positive throat culture or RADT, or elevated/rising streptococcal antibodies (ASO, anti-DNase B). Recent scarlet fever or a new murmur consistent with rheumatic carditis can support the history.
For moderate/high-risk settings, polyarthralgia may count as a major criterion; monoarthritis may be major if no better explanation and labs support inflammation. Fever and ESR/CRP cut points can be slightly lower. Always follow local thresholds.
Recurrent episodes have modified requirements (e.g., 2 major, or 1 major + 2 minor, or multiple minor with evidence of GAS). Apply the AHA 2015 update and local pathway; treat suspected recurrences promptly.
Echo is recommended for all suspected ARF. Involve cardiology early for any murmurs, heart failure, conduction issues, or diagnostic uncertainty. Follow their guidance on follow-up imaging and prophylaxis.
Not reliably in evolving presentations. Repeat assessment and serial data can be necessary when clinical suspicion remains despite early nondiagnostic labs.
Include risk classification, criteria timeline, GAS evidence status, cardiac findings, and the specific decision needed from specialists. This shortens handoff delays and improves treatment clarity.